Industry News

Nov 24, 2014
Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.
Nov 20, 2014
Ralph G. Neas, president and CEO of the Generic Pharmaceutical Association, requests that Congress get involved in the support of a more competitive drug market.
Nov 20, 2014
By BioPharm International Editors
FDA opens public docket on proposed criteria for “first generic” ANDAs.
Nov 20, 2014
The United States government is ramping up support for formulation, production, and packaging of Ebola treatments.
Nov 20, 2014
By BioPharm International Editors
USP and ChP jointly host two-day meeting to strengthen cooperation.
Nov 19, 2014
A new report from The Pharmaceutical Care Management Association alleges that FDA hinders competition in the pharmaceutical industry and influences how a drug's price is calculated.
Nov 17, 2014
After being plagued by numerous delays, Lemtrada (alemtuzumab) has finally been approved by FDA for the treatment of multiple sclerosis.
Nov 17, 2014
Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.
Nov 17, 2014
By BioPharm International Editors
FDA issues draft guidance on rare pediatric disease priority review vouchers in accordance with FDASIA.
Nov 13, 2014
By BioPharm International Editors
USP releases compendium of quality standards for compounded medicines.
native1_300x100
lorem ipsum